Achieve Pharma UK Limited
Registered name: ACHIEVE PHARMA UK LIMITED
Part of Achieve Life Sciences, Inc. groupAchieve Pharma UK Limited made £2.1m revenue and a £535k loss in the year to 31 Dec 2023. read from filing text
Achieve Pharma UK Limited’s revenue grew 78% to £2.1m in the year to 31 Dec 2023, with a loss of £535k and 5 employees. The company is classified under “other research and experimental development on natural sciences and engineering” and is based in Henley-on-Thames; we hold 2 years of its filed accounts.
- Status
- Active
- Location
- Henley-on-Thames, South East
- Age
- 17 yrs · since 2008
- Type
- Private Limited Company
Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “The immediate and ultimate parent Company is Achieve Life Sciences Inc. a Company registered in the United States of America, 520 Pike Street,”
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Dec 2022 | 31 Dec 2023 |
|---|---|---|
| Disclosure | Full P&Lread from filing text | Full P&Lread from filing text |
| Profit & loss | ||
| Revenue (turnover) | £1.2m | £2.1m |
| Profit before tax | −£89.2k | −£535k |
| Profit after tax | −£89.2k | −£535k |
| Profit (best available) | −£89.2k | −£535k |
| Employees (average) | 4 | 5 |
| Ratios | ||
| Profit margin | −7.6% | −25.6% |
| Revenue per employee | £293k | £417k |
| Profit per employee | −£22.3k | −£107k |
| Growth (year on year) | ||
| Revenue growth | — | ▲78.1% |
| Headcount growth | — | ▲25% |
| Balance sheet — indirect signals, not revenue | ||
| Cash at bank | £101k | £159k |
| Net assets | £486k | −£48.4k |
| Fixed assets | £2k | £5.3k |
| Current assets | £1.1m | £823k |
| Debtors | £969k | £663k |
| Source | FullAccounts · bulk data Sep 2024 | FullAccounts · bulk data Sep 2024 |
How the business works
- Profit margin
- −25.6%
- Profit ÷ revenue.
- Gross margin
- —
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £417k
- Revenue ÷ average employees.
- Profit per employee
- −£107k
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- 0.3%
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- —
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- 31.8%
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- ▼110%
- Now −£48.4k
- Cash at bank
- ▲58%
- Now £159k
- Headcount
- ▲25%
- Now 5
- Deferred income
- —
- Now —
- Fixed assets
- ▲162%
- Now £5.3k
Group structure
Ownership chain
- Achieve Life Sciences, Inc. (registered outside the UK register)ultimate parent75–100%
- Achieve Pharma UK Limitedthis company
Bands show the share of ownership each company holds in the one below it.
From the Persons with Significant Control register (corporate controllers only).
Similar profitable businesses
- Sige Semiconductor (Europe) LimitedHove · Other research and experimental development on natural sciences and engineering
- Revenue
- £2.2m
- Profit
- £313k
- Staff
- 10
- Cambridge Environmental Research Consultants LimitedCambs · Other research and experimental development on natural sciences and engineering
- Revenue
- £2m
- Profit
- £212k
- Staff
- 28
- Hessle Dock Company LimitedEast Yorkshire · Other research and experimental development on natural sciences and engineering
- Revenue
- £1.8m
- Profit
- £171k
- Staff
- 13
- Future Geoscience LtdWelshpool · Other research and experimental development on natural sciences and engineering
- Revenue
- £1.7m
- Profit
- £72.7k
- Staff
- 2
- Cti Clinical Trial and Consulting Services UK LtdLondon · Other research and experimental development on natural sciences and engineering
- Revenue
- £2.9m
- Profit
- £528k
- Staff
- 20
- Jumo Europe LimitedLondon · Other research and experimental development on natural sciences and engineering
- Revenue
- £1.5m
- Profit
- £38.7k
- Staff
- 7
Sources
Latest figures from FullAccounts for the year to 31 Dec 2023 (profit −£535k), from the Companies House accounts bulk data published Sep 2024. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.